RNA Manufacturing Solutions
-
Labscale Lipid Nanoparticle Production: IJM NanoScaler
12/9/2024
The benchtop IJM NanoScaler system is designed for lipid nanoparticle R&D – allowing scientists to screen for the optimal process parameters for the formulation of API-containing lipid nanoparticles.
-
Achieve Higher Targeted Concentrations
9/30/2025
High-concentration protein therapies offer patient and clinician benefits, but processing them introduces pressure-related challenges. Learn more about how pressure impacts final concentration outcomes.
-
Process Chemicals For RNA Drug Manufacturing
Make use of our portfolio of raw materials required for mRNA with an integrated offering for all process steps, from plasmid DNA (pDNA) to mRNA synthesis to final formulation.
-
Filtration Hardware
7/8/2024
Learn in detail about a flexible cross flow filtration solution designed for sample concentration, diafiltration (buffer exchange), cell harvest, and clarification.
-
Compact Oligonucleotide Synthesizer
2/10/2023
Looking for a user-friendly and compact oligonucleotide synthesizer with a large scale range? Discover a pilot-scale system that will take your drug through clinical development.
-
Supporting Bench To Production Applications For Multiple Industries
10/17/2023
Grow and scale up your manufacturing with the right support, and choose from 92,000+ chemicals provided through an extensive global network of 3,500+ manufacturers.
-
Fit-For-Purpose And GMP Grade mRNA Reagents
3/24/2025
Ensure the safety and efficacy of your mRNA therapeutics with high-quality, GMP-grade reagents from a trusted partner with a multi-tiered quality approach to deliver manufacturing certainty.
-
Pre-GMP mRNA And LNP Development
11/26/2024
Leverage Pre-GMP mRNA and LNP development services to streamline process development, mitigate risks early, and accelerate your path to market with high-quality, compliant drug products.
-
Omics In Health
12/10/2024
Explore advanced omics technologies, including genomics, proteomics, and microbiomics, with bioinformatics and machine learning to solve complex health challenges in diagnostics and drug development.
-
Non-Viral In Vivo Transfection - Cationic Lipids For LNP Formulation
7/13/2023
LipidBrick® IM21.7c
- Efficient: Modulates LNP properties to adapt the biodistribution depending on the therapeutic purpose
- Secure: Use a unique lipid structure protected by an independent patent owned by Polyplus®
- Accelerate your project: in vitro and in vivo proof of concept have been successfully performed